June 1, 2020 / 11:17 AM / 2 months ago

BRIEF-CTI Biopharma Enrolls First Patient In Covid-19 Pre-Vent Phase 3 Trial

June 1 (Reuters) - CTI Biopharma Corp:

* CTI BIOPHARMA ANNOUNCES ENROLLMENT OF FIRST PATIENT IN COVID-19 PRE-VENT PHASE 3 CLINICAL TRIAL

* COMPANY EXPECTS TO REPORT TOPLINE DATA BY END OF 2020

* CTI BIOPHARMA-PRE-VENT TO COMPARE PACRITINIB PLUS STANDARD OF CARE VERSUS PLACEBO & STANDARD OF CARE IN 358 HOSPITALIZED PATIENTS WITH SEVERE COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below